BioCentury | Mar 11, 2013
Clinical News

APN201: Phase Ib data

...in 20 breast cancer patients who received radiation therapy after breast-preserving surgery showed that once-daily APN201...
...to radiation therapy was well tolerated with no treatment-related adverse events reported. Apeiron also said APN201...
...time to occurrence of grade 2 dermatitis. The company plans to start clinical testing of APN201...
BioCentury | Mar 5, 2012
Clinical News

APN201: Phase Ib started

...Apeiron began a double-blind, placebo-controlled, Austrian Phase Ib trial to evaluate APN201 given prior to radiation...
...Apeiron Biologics AG , Vienna, Austria Polymun Scientific Immunbiologische Forschung GmbH , Vienna, Austria Product: APN201...
BioCentury | Feb 28, 2011
Product Development

Two for one in neuroblastoma

...exclusive, worldwide rights to Polymun's recombinant human superoxide dismutase (SOD), APN201 . Apeiron is developing APN201...
Items per page:
1 - 3 of 3